RNAC
#3461
Cartesian Therapeutics, Inc. - Common Stock
8.6 2 USD
0.00%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-0.12%
Monthly Change
0.00%
6 month change
+17.44%
Year Change
-5.90%
Previous Close
8.6 3
Open
8.6 2
Low
8.6 2
High
8.6 2
Volume
19
Financials
- Market Capitalization 253.27 M
- Employee 75
- Founded 2007
- CEO N/A
- Website www.cartesiantherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG001J19Q25
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-1.06
Price to sales ratio
90.42
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3440 |  NAGE Niagen Bioscience, Inc. - Common Stock | 3.29 USD | -5.19% | -4.08% | -6.53% | -33.94% | 262.03 M USD | ||
| 3459 |  SRZN Surrozen, Inc. - Common Stock | 21.88 USD | -4.08% | -4.87% | -5.65% | +162.98% | 254.03 M USD | ||
| 3494 |  ACIU AC Immune SA - Common Stock | 2.41 USD | -1.63% | -4.74% | +1.69% | +17.56% | 245.20 M USD | ||
| 3509 |  FULC Fulcrum Therapeutics, Inc. - Common Stock | 3.59 USD | +1.41% | -4.27% | +1.70% | -54.44% | 239.21 M USD |
Frequently asked questions about Cartesian Therapeutics, Inc. - Common Stock
What is the Cartesian Therapeutics, Inc. - Common Stock stock price today?
The current price of Cartesian Therapeutics, Inc. - Common Stock (RNAC) is 8.62. Over the past 24 hours, the stock has changed by -0.12%. Follow the RNAC chart for real-time price dynamics.
What is the stock ticker of Cartesian Therapeutics, Inc. - Common Stock?
Cartesian Therapeutics, Inc. - Common Stock trades under the ticker RNAC. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Cartesian Therapeutics, Inc. - Common Stock stock going up?
RNAC has changed by -13.19% over the last week, 0.00% over the last month, and -5.90% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Cartesian Therapeutics, Inc. - Common Stock net income for the last quarter?
Cartesian Therapeutics, Inc. - Common Stock reported net income of -39.18 M for the last quarter. The previous quarter showed -92.58 M, which means net income changed by +57.68%.
How many employees does Cartesian Therapeutics, Inc. - Common Stock have?
As of the latest available data, Cartesian Therapeutics, Inc. - Common Stock has 75 employees. Workforce size can provide additional context about the company's scale and operations.
What is Cartesian Therapeutics, Inc. - Common Stock EBITDA?
Cartesian Therapeutics, Inc. - Common Stock EBITDA is -25.05 M, and its EBITDA margin is -32.11 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Cartesian Therapeutics, Inc. - Common Stock stock?
You can buy Cartesian Therapeutics, Inc. - Common Stock (RNAC) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Cartesian Therapeutics, Inc. - Common Stock stock?
Investing in Cartesian Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the RNAC chart and related analysis on metatrader.com as part of your research.